UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Self-assembled mRNA vaccines

Advanced drug delivery reviews, 2021-03, Vol.170, p.83-112

2021

Volltextzugriff (PDF)

Non-viral COVID-19 vaccine delivery systems

Advanced drug delivery reviews, 2021-02, Vol.169, p.137-151

2021

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

The Lancet (British edition), 2020-06, Vol.395 (10240), p.1845-1854

2020

Volltextzugriff (PDF)

A Thermostable mRNA Vaccine against COVID-19

Cell, 2020-09, Vol.182 (5), p.1271-1283.e16

2020

Volltextzugriff (PDF)

Comparison of DNA and mRNA vaccines against cancer

Drug discovery today, 2020-03, Vol.25 (3), p.552-560

2020

Volltextzugriff (PDF)

Recombinant protein vaccines, a proven approach against coronavirus pandemics

Advanced drug delivery reviews, 2021-03, Vol.170, p.71-82

2021

Volltextzugriff (PDF)

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Advanced drug delivery reviews, 2021-03, Vol.170, p.113-141

2021

Volltextzugriff (PDF)

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

The Lancet (British edition), 2018-12, Vol.392 (10165), p.2718-2727

2018

Volltextzugriff (PDF)

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

Vaccine, 2016-01, Vol.34 (3), p.313-319

2016

Volltextzugriff (PDF)

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus , is safe and immunogenic in healthy adults

Vaccine, 2012-12, Vol.30 (52), p.7594-7600

2012

Volltextzugriff (PDF)

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2017-02, Vol.389 (10069), p.621-628

2017

Volltextzugriff (PDF)

Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across

Advanced drug delivery reviews, 2021-09, Vol.176, p.113900-113900, Article 113900

2021

Volltextzugriff (PDF)

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

Immunity (Cambridge, Mass.), 2021-08, Vol.54 (8), p.1869-1882.e6

2021

Volltextzugriff (PDF)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

Vaccine, 2017-03, Vol.35 (12), p.1586-1589

2017

Volltextzugriff (PDF)

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

Cell, 2016-09, Vol.166 (6), p.1459-1470.e11

2016

Volltextzugriff (PDF)

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines

Biomedicine & pharmacotherapy, 2022-02, Vol.146, p.112527-112527, Article 112527

2022

Volltextzugriff (PDF)

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.351-357

2016

Volltextzugriff (PDF)

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Vaccine, 2013-01, Vol.31 (3), p.524-532

2013

Volltextzugriff (PDF)

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

European journal of cancer (1990), 2021-09, Vol.155, p.291-293

2021

Volltextzugriff (PDF)

Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer

Bioelectrochemistry (Amsterdam, Netherlands), 2022-04, Vol.144, p.107994-107994, Article 107994

2022

Volltextzugriff (PDF)

Preclinical and clinical development of a dengue recombinant subunit vaccine

Vaccine, 2015-12, Vol.33 (50), p.7126-7134

2015

Volltextzugriff (PDF)

Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks

Vaccine, 2024-07, Vol.42 (18), p.3756-3767

2024

Volltextzugriff (PDF)

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

Vaccine, 2015-09, Vol.33 (39), p.5064-5071

2015

Volltextzugriff (PDF)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

Vaccine, 2015-11, Vol.33 (48), p.6800-6808

2015

Volltextzugriff (PDF)

Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles

Journal of controlled release, 2016-03, Vol.226, p.98-106

2016

Volltextzugriff (PDF)

1 – 25 von 1.574

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.560)
Mit Volltextzugriff
(1.574)

Publikationsform

Artikel
(1.573)
Tagungsberichte
(1)

Sprache

Englisch
(1.574)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.454)
Life Sciences & Biomedicine
(1.451)
Animals
(1.306)
Vaccines, Synthetic - Administration & Dosage
(1.256)
Vaccines, Synthetic - Immunology
(1.201)
Immunology
(1.085)
Medicine, Research & Experimental
(932)
Research & Experimental Medicine
(932)
Biological And Medical Sciences
(814)
Female
(735)
Vaccines
(735)
Fundamental And Applied Biological Sciences. Psychology
(731)
Microbiology
(716)
Mice
(683)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(659)
Humans
(609)
Allergy And Immunology
(538)
Vaccines, Synthetic - Genetics
(500)
Virology
(486)
Immunization
(483)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Vaccine
(1.003)
Virology
(80)
Antiviral Research
(37)
Virus Research
(33)
Veterinary Immunology And Immunopathology
(29)
Microbes And Infection
(26)
The Lancet
(22)
Journal Of Virological Methods
(21)
Microbial Pathogenesis
(20)
Veterinary Microbiology
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Self-assembled mRNA vaccines

Non-viral COVID-19 vaccine delivery systems

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

A Thermostable mRNA Vaccine against COVID-19

Comparison of DNA and mRNA vaccines against cancer

Recombinant protein vaccines, a proven approach against coronavirus pandemics

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus , is safe and immunogenic in healthy adults

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines

Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors

Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer

Preclinical and clinical development of a dengue recombinant subunit vaccine

Efficacy of live and inactivated recombinant Newcastle disease virus vaccines expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza in SPF chickens, Broilers, and domestic ducks

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles

Aktive Filter

Suchergebnisse filtern